Literature DB >> 33563983

Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles.

Philip J M Brouwer1, Aleksandar Antanasijevic2, Marlon de Gast1, Joel D Allen3, Tom P L Bijl1, Anila Yasmeen4, Rashmi Ravichandran5,6, Judith A Burger1, Gabriel Ozorowski2, Jonathan L Torres2, Celia LaBranche7, David C Montefiori7, Rajesh P Ringe4,8, Marit J van Gils1, John P Moore4, Per Johan Klasse4, Max Crispin3, Neil P King9,10, Andrew B Ward11, Rogier W Sanders12,13.   

Abstract

The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivalent antigen presentation on nanoparticles is an established strategy to increase vaccine-driven immune responses. However, due to nanoparticle instability in vivo, the display of non-native Env structures, and the inaccessibility of many neutralizing antibody (NAb) epitopes, the effects of nanoparticle display are generally modest for Env trimers. Here, we generate two-component self-assembling protein nanoparticles presenting twenty SOSIP trimers of the clade C Tier-2 genotype 16055. We show in a rabbit immunization study that these nanoparticles induce 60-fold higher autologous Tier-2 NAb titers than the corresponding SOSIP trimers. Epitope mapping studies reveal that the presentation of 16055 SOSIP trimers on these nanoparticle focuses antibody responses to an immunodominant apical epitope. Thus, these nanoparticles are a promising platform to improve the immunogenicity of Env trimers with apex-proximate NAb epitopes.

Entities:  

Year:  2021        PMID: 33563983      PMCID: PMC7873233          DOI: 10.1038/s41541-021-00285-9

Source DB:  PubMed          Journal:  NPJ Vaccines        ISSN: 2059-0105            Impact factor:   7.344


  53 in total

1.  Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission.

Authors:  Li Wu; Thomas D Martin; Mary Carrington; Vineet N KewalRamani
Journal:  Virology       Date:  2004-01-05       Impact factor: 3.616

2.  Automated molecular microscopy: the new Leginon system.

Authors:  Christian Suloway; James Pulokas; Denis Fellmann; Anchi Cheng; Francisco Guerra; Joel Quispe; Scott Stagg; Clinton S Potter; Bridget Carragher
Journal:  J Struct Biol       Date:  2005-07       Impact factor: 2.867

Review 3.  Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?

Authors:  P J Klasse; Gabriel Ozorowski; Rogier W Sanders; John P Moore
Journal:  Cell Host Microbe       Date:  2020-04-08       Impact factor: 21.023

4.  Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation.

Authors:  Hannah G Kelly; Hyon-Xhi Tan; Jennifer A Juno; Robyn Esterbauer; Yi Ju; Wenbo Jiang; Verena C Wimmer; Brigette C Duckworth; Joanna R Groom; Frank Caruso; Masaru Kanekiyo; Stephen J Kent; Adam K Wheatley
Journal:  JCI Insight       Date:  2020-05-21

5.  HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies.

Authors:  Andrew T McGuire; Anita M Dreyer; Sara Carbonetti; Adriana Lippy; Jolene Glenn; Johannes F Scheid; Hugo Mouquet; Leonidas Stamatatos
Journal:  Science       Date:  2014-12-12       Impact factor: 47.728

6.  A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses.

Authors:  Jon M Steichen; Ying-Cing Lin; Colin Havenar-Daughton; Simone Pecetta; Gabriel Ozorowski; Jordan R Willis; Laura Toy; Devin Sok; Alessia Liguori; Sven Kratochvil; Jonathan L Torres; Oleksandr Kalyuzhniy; Eleonora Melzi; Daniel W Kulp; Sebastian Raemisch; Xiaozhen Hu; Steffen M Bernard; Erik Georgeson; Nicole Phelps; Yumiko Adachi; Michael Kubitz; Elise Landais; Jeffrey Umotoy; Amanda Robinson; Bryan Briney; Ian A Wilson; Dennis R Burton; Andrew B Ward; Shane Crotty; Facundo D Batista; William R Schief
Journal:  Science       Date:  2019-10-31       Impact factor: 47.728

Review 7.  Neutralization tiers of HIV-1.

Authors:  David C Montefiori; Mario Roederer; Lynn Morris; Michael S Seaman
Journal:  Curr Opin HIV AIDS       Date:  2018-03       Impact factor: 4.283

8.  Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo.

Authors:  Max Medina-Ramírez; Fernando Garces; Amelia Escolano; Patrick Skog; Steven W de Taeye; Ivan Del Moral-Sanchez; Andrew T McGuire; Anila Yasmeen; Anna-Janina Behrens; Gabriel Ozorowski; Tom L G M van den Kerkhof; Natalia T Freund; Pia Dosenovic; Yuanzi Hua; Alexander D Gitlin; Albert Cupo; Patricia van der Woude; Michael Golabek; Kwinten Sliepen; Tanya Blane; Neeltje Kootstra; Mariëlle J van Breemen; Laura K Pritchard; Robyn L Stanfield; Max Crispin; Andrew B Ward; Leonidas Stamatatos; Per Johan Klasse; John P Moore; David Nemazee; Michel C Nussenzweig; Ian A Wilson; Rogier W Sanders
Journal:  J Exp Med       Date:  2017-08-28       Impact factor: 14.307

9.  Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes.

Authors:  Talar Tokatlian; Daniel W Kulp; Andrew A Mutafyan; Christopher A Jones; Sergey Menis; Erik Georgeson; Mike Kubitz; Michael H Zhang; Mariane B Melo; Murillo Silva; Dong Soo Yun; William R Schief; Darrell J Irvine
Journal:  Sci Rep       Date:  2018-11-08       Impact factor: 4.379

10.  Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle.

Authors:  Philip J M Brouwer; Aleksandar Antanasijevic; Zachary Berndsen; Anila Yasmeen; Brooke Fiala; Tom P L Bijl; Ilja Bontjer; Jacob B Bale; William Sheffler; Joel D Allen; Anna Schorcht; Judith A Burger; Miguel Camacho; Daniel Ellis; Christopher A Cottrell; Anna-Janina Behrens; Marco Catalano; Iván Del Moral-Sánchez; Thomas J Ketas; Celia LaBranche; Marit J van Gils; Kwinten Sliepen; Lance J Stewart; Max Crispin; David C Montefiori; David Baker; John P Moore; Per Johan Klasse; Andrew B Ward; Neil P King; Rogier W Sanders
Journal:  Nat Commun       Date:  2019-09-19       Impact factor: 14.919

View more
  11 in total

1.  SOSIP Trimer-Specific Antibodies Isolated from a Simian-Human Immunodeficiency Virus-Infected Monkey with versus without a Pre-blocking Step with gp41.

Authors:  Natasha N Duggan; Kim L Weisgrau; Diogo M Magnani; Eva G Rakasz; Ronald C Desrosiers; Jose M Martinez-Navio
Journal:  J Virol       Date:  2021-11-03       Impact factor: 6.549

2.  Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers.

Authors:  Kwinten Sliepen; Edith Schermer; Ilja Bontjer; Judith A Burger; Réka Felfödiné Lévai; Philipp Mundsperger; Philip J M Brouwer; Monica Tolazzi; Attila Farsang; Dietmar Katinger; John P Moore; Gabriella Scarlatti; Robin J Shattock; Quentin J Sattentau; Rogier W Sanders
Journal:  NPJ Vaccines       Date:  2021-08-17       Impact factor: 9.399

3.  Immunopotentiation by Lymph-Node Targeting of a Malaria Transmission-Blocking Nanovaccine.

Authors:  Gregory P Howard; Nicole G Bender; Prachi Khare; Borja López-Gutiérrez; Vincent Nyasembe; William J Weiss; Jerry W Simecka; Timothy Hamerly; Hai-Quan Mao; Rhoel R Dinglasan
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 8.786

Review 4.  Protein engineering strategies for rational immunogen design.

Authors:  Timothy M Caradonna; Aaron G Schmidt
Journal:  NPJ Vaccines       Date:  2021-12-17       Impact factor: 7.344

5.  Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization.

Authors:  Safia S Aljedani; Tyler J Liban; Karen Tran; Ganesh Phad; Suruchi Singh; Viktoriya Dubrovskaya; Pradeepa Pushparaj; Paola Martinez-Murillo; Justas Rodarte; Alex Mileant; Vidya Mangala Prasad; Rachel Kinzelman; Sijy O'Dell; John R Mascola; Kelly K Lee; Gunilla B Karlsson Hedestam; Richard T Wyatt; Marie Pancera
Journal:  PLoS Pathog       Date:  2021-09-24       Impact factor: 6.823

6.  Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates.

Authors:  Jelle van Schooten; Marlies M van Haaren; Hui Li; Laura E McCoy; Colin Havenar-Daughton; Christopher A Cottrell; Judith A Burger; Patricia van der Woude; Leanne C Helgers; Ilhan Tomris; Celia C Labranche; David C Montefiori; Andrew B Ward; Dennis R Burton; John P Moore; Rogier W Sanders; Shane Crotty; George M Shaw; Marit J van Gils
Journal:  PLoS Pathog       Date:  2021-08-25       Impact factor: 6.823

Review 7.  Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies.

Authors:  Barton F Haynes; Kevin Wiehe; Persephone Borrrow; Kevin O Saunders; Bette Korber; Kshitij Wagh; Andrew J McMichael; Garnett Kelsoe; Beatrice H Hahn; Frederick Alt; George M Shaw
Journal:  Nat Rev Immunol       Date:  2022-08-12       Impact factor: 108.555

8.  From structure to sequence: Antibody discovery using cryoEM.

Authors:  Aleksandar Antanasijevic; Charles A Bowman; Robert N Kirchdoerfer; Christopher A Cottrell; Gabriel Ozorowski; Amit A Upadhyay; Kimberly M Cirelli; Diane G Carnathan; Chiamaka A Enemuo; Leigh M Sewall; Bartek Nogal; Fangzhu Zhao; Bettina Groschel; William R Schief; Devin Sok; Guido Silvestri; Shane Crotty; Steven E Bosinger; Andrew B Ward
Journal:  Sci Adv       Date:  2022-01-19       Impact factor: 14.957

Review 9.  A Structural Update of Neutralizing Epitopes on the HIV Envelope, a Moving Target.

Authors:  Emma Parker Miller; Maxwell T Finkelstein; Molly C Erdman; Paul C Seth; Daniela Fera
Journal:  Viruses       Date:  2021-09-05       Impact factor: 5.048

10.  Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike.

Authors:  Ronald Derking; Joel D Allen; Christopher A Cottrell; Kwinten Sliepen; Gemma E Seabright; Wen-Hsin Lee; Yoann Aldon; Kimmo Rantalainen; Aleksandar Antanasijevic; Jeffrey Copps; Anila Yasmeen; Albert Cupo; Victor M Cruz Portillo; Meliawati Poniman; Niki Bol; Patricia van der Woude; Steven W de Taeye; Tom L G M van den Kerkhof; P J Klasse; Gabriel Ozorowski; Marit J van Gils; John P Moore; Andrew B Ward; Max Crispin; Rogier W Sanders
Journal:  Cell Rep       Date:  2021-04-06       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.